Búsqueda | Portal de Búsqueda de la BVS España

1.

Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts.

Kasprzak, A; Assadi, C; Nachtkamp, K; Rudelius, M; Haas, R; Giagounidis, A; Götze, K; Gattermann, N; Germing, U.

Ann Hematol; 102(1): 99-106, 2023 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-36409328

2.

Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysis.

Boquoi, A; Banahan, S M; Mohring, A; Savickaite, I; Strapatsas, J; Hildebrandt, B; Kobbe, G; Gattermann, N; Haas, R; Schroeder, T; Germing, U; Fenk, R.

Ann Hematol; 101(5): 1031-1038, 2022 May.

Artículo en Inglés | MEDLINE | ID: mdl-35262868

3.

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials.

Platzbecker, U; Fenaux, P; Adès, L; Giagounidis, A; Santini, V; van de Loosdrecht, A A; Bowen, D; de Witte, T; Garcia-Manero, G; Hellström-Lindberg, E; Germing, U; Stauder, R; Malcovati, L; Sekeres, Mikkael A; Steensma, David P; Gloaguen, S.

Blood; 133(10): 1020-1030, 2019 03 07.

Artículo en Inglés | MEDLINE | ID: mdl-30404811

4.

Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes.

Kasprzak, A; Nachtkamp, K; Kondakci, M; Schroeder, T; Kobbe, G; Kündgen, A; Kaivers, J; Rautenberg, C; Haas, R; Gattermann, N; Bonadies, N; Germing, U.

Ann Hematol; 100(2): 455-463, 2021 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-33159566

5.

Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.

Machherndl-Spandl, Sigrid; Sega, W; Bösmüller, H; Germing, U; Gruber, Ch; Nachtkamp, K; Reinecke, P; Sperr, W R; Wimazal, F; Müllauer, L; Sotlar, K; Horny, H P; Tüchler, H; Valent, P; Krieger, O.

Ann Hematol; 93(1): 57-64, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-24241126

6.

Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals.

Schwab, K S; Hahn-Ast, C; Heinz, W J; Germing, U; Egerer, G; Glasmacher, A; Leyendecker, C; Marklein, G; Nellessen, C M; Brossart, P; von Lilienfeld-Toal, M.

Infection; 42(1): 97-104, 2014 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-23979853

7.

An unusual presentation of a common infection.

Richter, J; Quintanilla-Martinez, L; Bienemann, K; Zeus, T; Germing, U; Sander, O; Kandolf, R; Häussinger, D; Klingel, K.

Infection; 41(2): 565-9, 2013 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-22926562

8.

The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T.

Kaivers, J; Peters, J; Rautenberg, C; Schroeder, T; Kobbe, G; Hildebrandt, B; Haas, R; Germing, U; Bennett, J M.

Leuk Res; 112: 106757, 2022 01.

Artículo en Inglés | MEDLINE | ID: mdl-34864369

9.

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Kuendgen, A; Nomdedeu, M; Tuechler, H; Garcia-Manero, G; Komrokji, R S; Sekeres, M A; Della Porta, M G; Cazzola, M; DeZern, A E; Roboz, G J; Steensma, D P; Van de Loosdrecht, A A; Schlenk, R F; Grau, J; Calvo, X; Blum, S; Pereira, A; Valent, P; Costa, D; Giagounidis, A; Xicoy, B; Döhner, H; Platzbecker, U; Pedro, C; Lübbert, M; Oiartzabal, I; Díez-Campelo, M; Cedena, M T; Machherndl-Spandl, S; López-Pavía, M; Baldus, C D; Martinez-de-Sola, M; Stauder, R; Merchan, B; List, A; Ganster, C; Schroeder, T; Voso, M T; Pfeilstöcker, M; Sill, H; Hildebrandt, B; Esteve, J; Nomdedeu, B; Cobo, F; Haas, R; Sole, F; Germing, U; Greenberg, P L; Haase, D; Sanz, G.

Leukemia; 35(3): 835-849, 2021 03.

Artículo en Inglés | MEDLINE | ID: mdl-32595214

10.

Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients.

Schroeder, T; Ruf, L; Bernhardt, A; Hildebrandt, B; Aivado, M; Aul, C; Gattermann, N; Haas, R; Germing, U.

Ann Oncol; 21(11): 2267-2271, 2010 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-20439346

11.

Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.

Nösslinger, T; Tüchler, H; Germing, U; Sperr, W R; Krieger, O; Haase, D; Lübbert, M; Stauder, R; Giagounidis, A; Valent, P; Pfeilstöcker, M.

Ann Oncol; 21(1): 120-5, 2010 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19605511

12.

A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma.

Kobbe, G; Bruns, I; Schroeder, T; Czibere, A; Warnecke, J; Hieronimus, N; Safaian, N; Kondakci, M; Saure, C; Germing, U; Haas, R; Fenk, R.

Ann Oncol; 21(9): 1898-1904, 2010 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-20233744

13.

[Myelodysplastic syndromes]. / Myelodysplastische Syndrome.

Aul, C; Giagounidis, A; Germing, U.

Internist (Berl); 51(2): 169-82; quiz 183-4, 2010 Feb.

Artículo en Alemán | MEDLINE | ID: mdl-20082063

14.

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.

Nachtkamp, K; Strupp, C; Vukelja, M; Kasprzak, A; Haase, D; Ganster, C; Hildebrandt, B; Betz, B; Giagounidis, A; Aul, C; Blum, S; Hofmann, W K; Pfeilstöcker, M; Valent, P; Lübbert, M; Seidl, M; Rudelius, M; Stauder, R; Krieger, O; Götze, K S; Bobak, J; Kündgen, A; Schulz, F; Dietrich, S; Kobbe, G; Gattermann, N; Germing, U.

Leukemia; 38(2): 442-445, 2024 02.

Artículo en Inglés | MEDLINE | ID: mdl-38263435

15.

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin.

Lim, Z Y; Killick, S; Germing, U; Cavenagh, J; Culligan, D; Bacigalupo, A; Marsh, J; Mufti, G J.

Leukemia; 21(7): 1436-41, 2007 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-17507999

16.

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.

Matsuda, A; Germing, U; Jinnai, I; Iwanaga, M; Misumi, M; Kuendgen, A; Strupp, C; Miyazaki, Y; Tsushima, H; Sakai, M; Bessho, M; Gattermann, N; Aul, C; Tomonaga, M.

Leukemia; 21(4): 678-86, 2007 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-17268513

17.

Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.

Schuler, E; Frank, F; Hildebrandt, B; Betz, B; Strupp, C; Rudelius, M; Aul, C; Schroeder, T; Gattermann, N; Haas, R; Germing, U.

Leuk Res; 65: 1-4, 2018 02.

Artículo en Inglés | MEDLINE | ID: mdl-29216536

18.

The IPSS-R has prognostic impact in untreated patients with MDS del(5q).

Kaivers, J; Lauseker, M; Hildebrandt, B; Fenaux, P; Pfeilstöcker, M; Valent, P; Platzbecker, U; Latagliata, R; Oliva, E N; Xicoy, B; Götze, K; Ganster, C; Haase, D; Bug, G; Kündgen, A; Gattermann, N; Haas, R; Germing, U.

Leuk Res; 72: 27-33, 2018 09.

Artículo en Inglés | MEDLINE | ID: mdl-30075323

19.

A pilot study of bendamustine in elderly patients with high-risk MDS and AML.

Strupp, C; Knipp, S; Hartmann, J; Gattermann, N; Haas, R; Germing, U.

Leuk Lymphoma; 48(6): 1161-6, 2007 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-17577779

20.

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

Germing, U; Hildebrandt, B; Pfeilstöcker, M; Nösslinger, T; Valent, P; Fonatsch, C; Lübbert, M; Haase, D; Steidl, C; Krieger, O; Stauder, R; Giagounidis, A A N; Strupp, C; Kündgen, A; Mueller, T; Haas, R; Gattermann, N; Aul, C.

Leukemia; 19(12): 2223-31, 2005 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-16193087

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: